ROCHESTER, Minn. - According to the National Multiple Sclerosis Society more than 2.3-million people have the disease worldwide, but there is good news on the horizon.
Mayo Clinic Neurologist Dr. Mark Keegan, said the advancements in research are promising for patients. He explained that research is allowing them to better understand what causes inflammation and progression of the disease.
"I think that's really our next big goal for Multiple Sclerosis is to stop getting worse with MS. I think that does take some more research as to what the cause of that is and why do people worsen and stop that and in fact reverse impairment due to Multiple Sclerosis," said Dr. Keegan.
MS is an autoimmune disease in which the bodies immune system attacks the central nervous system afffecting the brain, optic nerve and spinal cord. Dr. Keegan stressed that the symptoms don't look the same in every person.
According to Mayo Clinic about 85-percent of Multiple Sclerosis patients have symptoms that relapse and then go into remission. Most people are diagnosed with the disease between the ages of 20-45.
Join us this Saturday, May 5, as we take part in Rochester's MS walk. Registration starts at 9a.m. and the walk gets underway at 10a.m.